CD276 and neoplasm: In animal models, targeting lactate metabolism (such as inhibiting LDHA or B7-H3) significantly suppresses tumor growth and activates tumor-infiltrating CD8+ T cells, providing a new strategy for combined immunotherapy (98) (Figure 2).